|
J Biol Chem, Vol. 274, Issue 17, 12087-12094, April 23, 1999
U50,488H-induced Internalization of the Human Opioid Receptor
Involves a -Arrestin- and Dynamin-dependent
Mechanism
RECEPTOR INTERNALIZATION IS NOT REQUIRED FOR
MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION
Jian-Guo
Li,
Lai-Yi
Luo,
Jason G.
Krupnick ,
Jeffrey L.
Benovic , and
Lee-Yuan
Liu-Chen
From the Department of Pharmacology, Temple University School of
Medicine, Philadelphia, Pennsylvania 19140 and the
Department of Microbiology and Immunology, Kimmel Cancer
Institute, Thomas Jefferson University,
Philadelphia, Pennsylvania 19107
Agonist-promoted internalization of some G
protein-coupled receptors has been shown to mediate receptor
desensitization, resensitization, and down-regulation. In this study,
we investigated whether opioids induced internalization of the human
and rat opioid receptors stably expressed in Chinese hamster ovary
cells, the potential mechanisms involved in this process and its
possible role in activation of mitogen-activated protein (MAP) kinase.
Exposure of the human receptor to the agonists U50,488H, U69,593,
ethylketocyclazocine, or tifluadom, but not etorphine, promoted
receptor internalization. However, none of these agonists induced
significant internalization of the rat opioid receptor.
U50,488H-induced human receptor internalization was time- and
concentration-dependent, with 30-40% of the receptors
internalized following a 30-min exposure to 1 µM
U50,488H. Agonist removal resulted in the receptors gradually returning
to the cell surface over a 60-min period. The antagonist naloxone
blocked U50,488H-induced internalization without affecting internalization itself, while pretreatment with pertussis toxin had no
effect on U50,488H-induced internalization. In contrast, incubation
with sucrose (0.4-0.8 M) significantly reduced
U50,488H-induced internalization of the receptor. While
co-expression of the wild type GRK2, -arrestin, or dynamin I had no
effect on receptor internalization, co-expression of the dominant
negative mutants GRK2-K220R, -arrestin (319-418), or dynamin I-K44A
significantly inhibited receptor internalization. Whether receptor
internalization is critical for MAP kinase activation was next
investigated. Co-expression of dominant negative mutants of
-arrestin or dynamin I, which greatly reduced U50,488H-induced
internalization, did not affect MAP kinase activation by the agonist.
In addition, etorphine, which did not promote human receptor
internalization, was able to fully activate MAP kinase. Moreover,
U50,488H or etorphine stimulation of the rat receptor, which did
not undergo internalization, also effectively activated MAP kinase.
Thus, U50,488H-induced internalization of the human opioid receptor
in Chinese hamster ovary cells occurs via a GRK-, -arrestin-, and
dynamin I-dependent process that likely involves
clathrin-coated pits. In addition, internalization of the receptor
is not required for activation of MAP kinase.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Xu, V. A. Kanda, E. Choi, G. Panaghie, T. K. Roepke, S. A. Gaeta, D. J. Christini, D. J. Lerner, and G. W. Abbott
MinK-dependent internalization of the IKs potassium channel
Cardiovasc Res,
June 1, 2009;
82(3):
430 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Li, D. S. Haines, and L.-Y. Liu-Chen
Agonist-Promoted Lys63-Linked Polyubiquitination of the Human {kappa}-Opioid Receptor Is Involved in Receptor Down-Regulation
Mol. Pharmacol.,
April 1, 2008;
73(4):
1319 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, Y. Chen, W. Xu, D. Y.W. Lee, Z. Ma, S. M. Rawls, A. Cowan, and L.-Y. Liu-Chen
2-Methoxymethyl-Salvinorin B Is a Potent {kappa} Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin A
J. Pharmacol. Exp. Ther.,
March 1, 2008;
324(3):
1073 - 1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wang, A. Bisello, Y. Yang, G. G. Romero, and P. A. Friedman
NHERF1 Regulates Parathyroid Hormone Receptor Membrane Retention without Affecting Recycling
J. Biol. Chem.,
December 14, 2007;
282(50):
36214 - 36222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, C. Chen, Y. Wang, and L.-Y. Liu-Chen
Ligands Regulate Cell Surface Level of the Human {kappa} Opioid Receptor by Activation-Induced Down-Regulation and Pharmacological Chaperone-Mediated Enhancement: Differential Effects of Nonpeptide and Peptide Agonists
J. Pharmacol. Exp. Ther.,
November 1, 2006;
319(2):
765 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Xu, S.-I. Yoon, P. Huang, Y. Wang, C. Chen, P. L.-G. Chong, and L.-Y. Liu-Chen
Localization of the {kappa} Opioid Receptor in Lipid Rafts
J. Pharmacol. Exp. Ther.,
June 1, 2006;
317(3):
1295 - 1306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, H. H. Loh, and P. Y. Law
Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor Internalization
Mol. Pharmacol.,
April 1, 2006;
69(4):
1421 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chen, J.-G. Li, Y. Chen, P. Huang, Y. Wang, and L.-Y. Liu-Chen
GEC1 Interacts with the {kappa} Opioid Receptor and Enhances Expression of the Receptor
J. Biol. Chem.,
March 24, 2006;
281(12):
7983 - 7993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, K. Tang, S. Inan, D. Siebert, U. Holzgrabe, D. Y.W. Lee, P. Huang, J.-G. Li, A. Cowan, and L.-Y. Liu-Chen
Comparison of Pharmacological Activities of Three Distinct {kappa} Ligands (Salvinorin A, TRK-820 and 3FLB) on {kappa} Opioid Receptors in Vitro and Their Antipruritic and Antinociceptive Activities in Vivo
J. Pharmacol. Exp. Ther.,
January 1, 2005;
312(1):
220 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev.,
September 1, 2004;
56(3):
351 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Brown and C. W. Bourque
Autocrine feedback inhibition of plateau potentials terminates phasic bursts in magnocellular neurosecretory cells of the rat supraoptic nucleus
J. Physiol.,
June 15, 2004;
557(3):
949 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. McLaughlin, L. C. Myers, P. E. Zarek, M. G. Caron, R. J. Lefkowitz, T. A. Czyzyk, J. E. Pintar, and C. Chavkin
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
J. Biol. Chem.,
January 16, 2004;
279(3):
1810 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, J.-G. Li, P. Huang, W. Xu, and L.-Y. Liu-Chen
Differential Effects of Agonists on Adenylyl Cyclase Superactivation Mediated by the {kappa} Opioid Receptors: Adenylyl Cyclase Superactivation Is Independent of Agonist-Induced Phosphorylation, Desensitization, Internalization, and Down-Regulation
J. Pharmacol. Exp. Ther.,
December 1, 2003;
307(3):
1127 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, H. H. Loh, and P.-Y. Law
The Intracellular Trafficking of Opioid Receptors Directed by Carboxyl Tail and a Di-leucine Motif in Neuro2A Cells
J. Biol. Chem.,
September 19, 2003;
278(38):
36848 - 36858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. McLaughlin, M. Xu, K. Mackie, and C. Chavkin
Phosphorylation of a Carboxyl-terminal Serine within the {kappa}-Opioid Receptor Produces Desensitization and Internalization
J. Biol. Chem.,
September 5, 2003;
278(36):
34631 - 34640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Marie, I. Lecoq, P. Jauzac, and S. Allouche
Differential Sorting of Human {delta}-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists
J. Biol. Chem.,
June 13, 2003;
278(25):
22795 - 22804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Li, F. Zhang, X.-L. Jin, and L.-Y. Liu-Chen
Differential Regulation of the Human kappa Opioid Receptor by Agonists: Etorphine and Levorphanol Reduced Dynorphin A- and U50,488H-Induced Internalization and Phosphorylation
J. Pharmacol. Exp. Ther.,
May 1, 2003;
305(2):
531 - 540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gerdin, M. I. Masana, D. Ren, R. J. Miller, and M. L. Dubocovich
Short-Term Exposure to Melatonin Differentially Affects the Functional Sensitivity and Trafficking of the hMT1 and hMT2 Melatonin Receptors
J. Pharmacol. Exp. Ther.,
March 1, 2003;
304(3):
931 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Eisinger, H. Ammer, and R. Schulz
Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization
J. Neurosci.,
December 1, 2002;
22(23):
10192 - 10200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhang, J. Li, J.-G. Li, and L.-Y. Liu-Chen
(-)U50,488H [(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] Induces Internalization and Down-Regulation of the Human, but not the Rat, kappa -Opioid Receptor: Structural Basis for the Differential Regulation
J. Pharmacol. Exp. Ther.,
September 1, 2002;
302(3):
1184 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Dolph
Book Review: Arrestin: Roles in the Life and Death of Retinal Neurons
Neuroscientist,
August 1, 2002;
8(4):
347 - 355.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Li, C. Chen, and L.-Y. Liu-Chen
Ezrin-Radixin-Moesin-binding Phosphoprotein-50/Na+/H+ Exchanger Regulatory Factor (EBP50/NHERF) Blocks U50,488H-induced Down-regulation of the Human kappa Opioid Receptor by Enhancing Its Recycling Rate
J. Biol. Chem.,
July 19, 2002;
277(30):
27545 - 27552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schulz, A. Wehmeyer, and K. Schulz
Visualizing Preference of G Protein-Coupled Receptor Kinase 3 for the Process of kappa -Opioid Receptor Sequestration
Mol. Pharmacol.,
June 1, 2002;
61(6):
1444 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Shah, J. Alberto Olivares-Reyes, A. Yesilkaya, and K. J. Catt
Independence of Angiotensin II-Induced MAP Kinase Activation from Angiotensin Type 1 Receptor Internalization in Clone 9 Hepatocytes
Mol. Endocrinol.,
March 1, 2002;
16(3):
610 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, J.-G. Li, C. Chen, F. Zhang, and L.-Y. Liu-Chen
Molecular Basis of Differences in (-)(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-Induced Desensitization and Phosphorylation between Human and Rat kappa -Opioid Receptors Expressed in Chinese Hamster Ovary Cells
Mol. Pharmacol.,
January 1, 2002;
61(1):
73 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hilairet, C. Belanger, J. Bertrand, A. Laperriere, S. M. Foord, and M. Bouvier
Agonist-promoted Internalization of a Ternary Complex between Calcitonin Receptor-like Receptor, Receptor Activity-modifying Protein 1 (RAMP1), and beta -Arrestin
J. Biol. Chem.,
November 2, 2001;
276(45):
42182 - 42190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Smith, R. Yu, and P. M. Hinkle
Activation of MAPK by TRH Requires Clathrin-Dependent Endocytosis and PKC but Not Receptor Interaction with {beta}-Arrestin or Receptor Endocytosis
Mol. Endocrinol.,
September 1, 2001;
15(9):
1539 - 1548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Cen, Y. Xiong, L. Ma, and G. Pei
Direct and Differential Interaction of {beta}-Arrestins with the Intracellular Domains of Different Opioid Receptors
Mol. Pharmacol.,
April 1, 2001;
59(4):
758 - 764.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. S. G. Ferguson
Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
Pharmacol. Rev.,
March 1, 2001;
53(1):
1 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-G. Li, J. L. Benovic, and L.-Y. Liu-Chen
Mechanisms of Agonist-Induced Down-Regulation of the Human kappa -Opioid Receptor: Internalization Is Required for Down-Regulation
Mol. Pharmacol.,
October 1, 2000;
58(4):
795 - 801.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Inoue and H. Ueda
Protein Kinase C-Mediated Acute Tolerance to Peripheral {micro}-Opioid Analgesia in the Bradykinin-Nociception Test in Mice
J. Pharmacol. Exp. Ther.,
May 1, 2000;
293(2):
662 - 669.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Maudsley, K. L. Pierce, A. M. Zamah, W. E. Miller, S. Ahn, Y. Daaka, R. J. Lefkowitz, and L. M. Luttrell
The beta 2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor
J. Biol. Chem.,
March 24, 2000;
275(13):
9572 - 9580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Zaki, D. E. Keith Jr., G. A. Brine, F. I. Carroll, and C. J. Evans
Ligand-Induced Changes in Surface {micro}-Opioid Receptor Number: Relationship to G Protein Activation?
J. Pharmacol. Exp. Ther.,
March 1, 2000;
292(3):
1127 - 1134.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Ferguson, K. R. Watterson, and T. M. Palmer
Subtype-Specific Kinetics of Inhibitory Adenosine Receptor Internalization Are Determined by Sensitivity to Phosphorylation by G Protein-Coupled Receptor Kinases
Mol. Pharmacol.,
March 1, 2000;
57(3):
546 - 552.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. L. Pierce, S. Maudsley, Y. Daaka, L. M. Luttrell, and R. J. Lefkowitz
Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors
PNAS,
February 15, 2000;
97(4):
1489 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-J. Cheng, J. Zhao, Y. Sun, W. Hu, Y.-L. Wu, B. Cen, G.-X. Wu, and G. Pei
beta -Arrestin Differentially Regulates the Chemokine Receptor CXCR4-mediated Signaling and Receptor Internalization, and This Implicates Multiple Interaction Sites between beta -Arrestin and CXCR4
J. Biol. Chem.,
January 28, 2000;
275(4):
2479 - 2485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Whistler and M. von Zastrow
Dissociation of Functional Roles of Dynamin in Receptor-mediated Endocytosis and Mitogenic Signal Transduction
J. Biol. Chem.,
August 27, 1999;
274(35):
24575 - 24578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Laporte, R. H. Oakley, J. A. Holt, L. S. Barak, and M. G. Caron
The Interaction of beta -Arrestin with the AP-2 Adaptor Is Required for the Clustering of beta 2-Adrenergic Receptor into Clathrin-coated Pits
J. Biol. Chem.,
July 21, 2000;
275(30):
23120 - 23126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-K. Tong, N. K. Hussain, A. G. Adams, J. P. O'Bryan, and P. S. McPherson
Intersectin Can Regulate the Ras/MAP Kinase Pathway Independent of Its Role in Endocytosis
J. Biol. Chem.,
September 15, 2000;
275(38):
29894 - 29899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Xiang, G.-H. Yu, J. Guo, L. Chen, W. Hu, G. Pei, and L. Ma
Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of delta -Opioid Receptor at Serine 344, Resulting in beta -Arrestin- and Clathrin-mediated Receptor Internalization
J. Biol. Chem.,
February 9, 2001;
276(7):
4709 - 4716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Schmidlin, O. Dery, K. O. DeFea, L. Slice, S. Patierno, C. Sternini, E. F. Grady, and N. W. Bunnett
Dynamin and Rab5a-dependent Trafficking and Signaling of the Neurokinin 1 Receptor
J. Biol. Chem.,
June 29, 2001;
276(27):
25427 - 25437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Penn, R. M. Pascual, Y.-M. Kim, S. J. Mundell, V. P. Krymskaya, R. A. Panettieri Jr., and J. L. Benovic
Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle
J. Biol. Chem.,
August 24, 2001;
276(35):
32648 - 32656.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|